In this study, we analyzed tumor samples from 85 EC patients using a targeted 50-gene next-generation sequencing (NGS) panel to classify tumors into four molecular subtypes: POLE mutated, mismatch repair-deficient (MMRd), p53-abnormal, and no specific molecular profile. The gene discussed is POLE; the disease is neoplasm.